&#xa0;
[normal]Written Evidence submitted by Dr Roland Salmon (CJD0002)[bold]What do you consider to be the likely prevalence of subclinical [bold]vCJD[bold] infection in the UK population? What evidence is there to support this [bold]view?[bold]&#xa0;
[normal]How might th[bold]is subclinical infection rate translate to future cases of [bold]vCJD[bold]? What are the key uncertainties in the relationship between subclinical and clinical [bold]vCJD[bold]?[bold]&#xa0;
[normal]&#xa0;
[normal]What are the likely rou[bold]tes of infection for [bold]vCJD[bold]? How have the potential modes of transmission changed over time?[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]What procedures are currently in place to monitor, [bold]control and prevent further spread of [bold]vCJD[bold] across the UK population? What more could b[bold]e done to reduce the risk pose[bold]d [bold]by [bold]vCJD[bold]?[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Other considerations[bold]&#xa0;
[normal]&#xa0;
[normal]References[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Declaration of interest[bold]I am currently Board Member for Wales and Chair of the Welsh Food Advisory Committee for the Food Standards Agency and also a member of the Department of Health’s Advisory Committee on Dangerous Pathogens and of t
[normal]hat committee’s Spongiform Encephalopathy Sub Group.  I am a member of the 
[normal]Conseil
[normal] 
[normal]d’Administration
[normal] (Management Advisory Board) of the 
[normal]Institut
[normal] de 
[normal]Veille
[normal] 
[normal]Sanitaire
[normal] (French National Institute for Public Health Surveillance).
[normal]&#xa0;
[normal]November 2013
[normal]&#xa0;
[normal]